SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-24-011210
Filing Date
2024-03-26
Accepted
2024-03-25 20:57:45
Documents
90
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 2123081
2 ex14.htm EX-14 204273
3 ex19.htm EX-19 84981
4 ex23-1.htm EX-23.1 3850
5 ex31-1.htm EX-31.1 12247
6 ex31-2.htm EX-31.2 12349
7 ex32.htm EX-32 8690
8 ex97.htm EX-97.1 55364
9 ex97.jpg GRAPHIC 2151
10 ex19_001.jpg GRAPHIC 2185
11 ex19_002.jpg GRAPHIC 2790
  Complete submission text file 0001493152-24-011210.txt   9712488

Data Files

Seq Description Document Type Size
12 XBRL SCHEMA FILE envb-20231231.xsd EX-101.SCH 76755
13 XBRL CALCULATION FILE envb-20231231_cal.xml EX-101.CAL 79447
14 XBRL DEFINITION FILE envb-20231231_def.xml EX-101.DEF 286491
15 XBRL LABEL FILE envb-20231231_lab.xml EX-101.LAB 594919
16 XBRL PRESENTATION FILE envb-20231231_pre.xml EX-101.PRE 448842
94 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 1399492
Mailing Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103 239-302-1707
Enveric Biosciences, Inc. (Filer) CIK: 0000890821 (see all company filings)

IRS No.: 954484725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38286 | Film No.: 24780735
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)